Tesamorelin
Stabilized GHRH Analogue
A stabilized analogue of GHRH studied for its effects on GH secretion and body composition.
Overview
Tesamorelin is a stabilized analogue of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid group added to improve stability. Research has investigated its effects on GH secretion, IGF-1 levels, and body composition, particularly visceral adipose tissue.
Research Information
Research on Tesamorelin has demonstrated its ability to significantly reduce visceral adipose tissue in various study populations. Studies have investigated its effects on GH-IGF-1 axis, lipid metabolism, and cognitive function. Research has also explored its effects on cardiovascular risk markers.
Research Dosage Reference
Research protocols use subcutaneous administration. Standard vials contain 1mg or 2mg lyophilized powder. All dosing information is for research reference only.
Related Research
Disclaimer: All information provided is for educational and research purposes only. This is not medical advice. These compounds are not approved for human use. Always consult with qualified professionals before conducting research.